Mounjaro (tirzepatide) is a key drug for type 2 diabetes. It also causes major weight loss. In 2024, major supply chain disruptions caused a shortage of this critical drug. This shortage has posed significant challenges for both patients and healthcare providers. It’s vital to know the causes of the shortage, its effects, and solutions. This ensures patients receive the care they need.

Understanding the Mounjaro Shortage

The Mounjaro shortage began in early 2024. Initial reports indicated sporadic shortages at pharmacies nationwide. By March, the situation had worsened. This led to widespread concern among patients and healthcare providers. As the shortage went on into June 2024, stakeholders held urgent talks to find and fix its causes.

Several factors have led to the continued shortage of Mounjaro.:

• Increased Demand: Mounjaro helps with diabetes and weight loss. This has boosted its popularity. As more patients seek out this medication, the supply has struggled to keep up.
• Manufacturing Constraints: The production of Mounjaro is complex and prone to bottlenecks. Manufacturing facilities have struggled to boost production to meet high demand. This has caused delays and a limited supply.
• Global Supply Chain Disruptions: Mounjaro’s production relies on raw materials. The global supply chain for them has faced many disruptions. These challenges have been worsened by geopolitical tensions, transport issues, and component shortages. Production capabilities are now more limited.

Impact of the Shortage on Patients

The Mounjaro shortage has deeply affected patients who need it for diabetes and weight loss.

Medication Shortage: It has made it hard for patients to get their meds. Pharmacies often run out of stock. This forces patients to visit multiple locations to find their prescriptions. This creates logistical challenges. It also causes stress and anxiety in patients who use Mounjaro for diabetes. In some cases, patients may wait weeks for a new supply. This can interrupt their treatment.

Potential Health Risks: Abruptly stopping Mounjaro can be dangerous for diabetics. The medication is vital for controlling blood sugar. Stopping it can lead to hyperglycemia, ketoacidosis, and other issues. Consistent medication is vital to prevent these outcomes. So, we must address the shortage quickly.

Limited Weight Loss Options: The shortage of Mounjaro is a setback for those using it for weight loss. Mounjaro has helped many patients lose weight. Its unavailability leaves them with few options. This disruption can stall their progress. It can harm their health. The lack of similar options makes it hard for patients to keep their weight loss. It shows the Mounjaro shortage’s wider impact beyond diabetes.

Coping with the Shortage: Communication and Alternatives

During this shortage, effective communication between patients and providers is vital. Patients should discuss their concerns and explore potential alternatives with their doctors. Several strategies can help manage the shortage and mitigate its impact on patients.

Switching to Available Dosages: One option is to switch to the available dosages of Mounjaro, such as the 2.5 mg pen. This dosage may not be ideal for long-term use. But, it can provide short-term relief. It can also extend the drug’s effects until higher doses are available again.

Exploring Alternative Incretin Drugs: Patients might consider other incretin drugs, like GLP-1 agonists.

The alternatives are:

Ozempic (semaglutide) is a weekly injection primarily used for managing type 2 diabetes. It helps regulate blood sugar levels and is also associated with significant weight loss benefits. Its long-acting formulation provides a steady release of medication over the week, making it a convenient option for those who prefer less frequent dosing.

Rybelsus (semaglutide), on the other hand, is taken as a daily oral pill. It is prescribed to help manage type 2 diabetes by enhancing blood sugar control. The oral form offers an alternative to injections, appealing to individuals who prefer a non-injection option. Although it requires daily administration, it provides similar benefits to Ozempic in terms of blood sugar control and weight management.

Victoza (liraglutide) is another medication for type 2 diabetes, administered through a daily injection. Like Ozempic, it helps with blood sugar control and weight loss, but it is a shorter-acting medication. While it is effective for managing diabetes, it is also approved for weight loss when combined with lifestyle changes.

Saxenda (liraglutide), also a daily injection, is specifically designed for weight management and obesity treatment. Although it can help with blood sugar control, its primary use is for weight loss. Saxenda contains a higher dose of liraglutide compared to Victoza, tailored specifically for weight management, and is not typically used solely for diabetes management.

Byetta (exenatide) is a medication that requires twice-daily injections and is used to manage type 2 diabetes. It helps improve blood sugar control and supports weight loss. Byetta is shorter-acting than other options and requires more frequent dosing, which might be less convenient but remains effective for diabetes management.

However, Novo Nordisk, the maker of Saxenda, has cautioned against switching to it. There may be supply issues and a high demand for weight loss drugs.

Regular Monitoring and Adjustments: Healthcare providers can help with the shortage. They can adjust treatment plans and monitor patients’ health. This proactive approach can reduce the risks of sudden medication changes. It will ensure patients get the care they need.

Duration of the Mounjaro Shortage

The FDA has said that shortages of Lilly’s Mounjaro and Zepbound will last at least until June 2024. This is due to the unprecedented demand and ongoing supply chain issues. The situation includes all doses of the Type 2 Diabetes (T2D) medication, Mounjaro. It is now in limited supply in Australia and is expected to last until August 2024.

Tracking Shortages and Supplies of GLP-1s

A good way to verify medication shortages is to check the FDA’s Drug Shortage List. it means the FDA is aware of the supply issue and is working with drug manufacturers to resolve it.

In May 2024, the telehealth company Ro launched a free tracker. It helps people stay updated on GLP-1 availability by drug type, dose, and location. This tracker combines Ro’s supply data, U.S. user reports, and FDA updates. Users can sign up for email alerts. They will be notified if a nearby GLP-1 medication is available or if its status on the FDA Drug Shortage List changes. They include info on pharmacies within 100 miles of the user’s zip code. It also explains how to transfer prescriptions between them.

How to Get a 3-Month Supply of Mounjaro

To get a 3-month supply of Mounjaro, patients should first consult their doctor. They must ensure that a 3-month supply is suitable for their treatment plan. Once the dosage is confirmed, patients can request a 3-month prescription. After getting the prescription, patients can visit Better You Rx. It’s a pharmacy-affiliated website based in Canada that can fulfill the order. Patients can save money by using discount codes. They can find them on the website. They can order a 3-month supply of Mounjaro. This method makes the medication affordable and accessible. It allows patients to continue their treatment without interruption.

Availability of Mounjaro in Canada

As of 2023, Mounjaro is now in Canada. It comes in six single-use vial doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Health Canada approved Mounjaro in November 2023, after the phase 3 SURPASS program. A press release highlighted the approval. Findings tested doses of 5 mg, 10 mg, and 15 mg.

The SURPASS program showed that Mounjaro works. Participants had lower HbA1c levels. The study found that at least 5% of patients had side effects. These included nausea, constipation, vomiting, indigestion, diarrhea, and stomach pain.

Where to Buy Mounjaro

Patients can buy Mounjaro (tirzepatide) from Better You Rx, a pharmacy-affiliated website. It offers a cheap and easy way to manage their medications. After a doctor’s visit and a prescription, patients can order Mounjaro on the Better You Rx site. Better You Rx delivers medication on time and reliably. This helps patients stick to their treatment regimens. Always follow your healthcare provider’s instructions. Stay updated on any changes to your medication.

Final Thoughts

In 2024, a Mounjaro shortage poses a challenge. It affects diabetes patients and those using it for weight loss. Effective communication with healthcare providers is crucial during this period. Patients should discuss other treatments with their doctors. They should also talk about ways to manage their conditions. It’s essential to stay updated on Mounjaro’s shortage. Use reliable sources, like the FDA and official pharmacies.

Patients can navigate this tough time by using resources and talking to providers. This will help them get the care they need. Proactive management, exploring other medications, and health monitoring can help. They can help with the Mounjaro shortage and keep patients on track with their treatment.

Better You Rx is committed to providing affordable, high-quality, online prescription meds from Canada. We aim to ensure patients get the best in convenience and reliability. Reach out to us today to discover more about our services and how we can support your healthcare needs.